{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:50:23Z","timestamp":1787500223177,"version":"build-2736575974"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,2]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Colistin is increasingly used as the last therapeutic option for the treatment of multidrug-resistant, Gram-negative bacterial infections. To ensure safe and efficacious use of colistin, therapeutic drug monitoring (TDM) is needed due to its narrow therapeutic window. This study aimed to evaluate the pharmacokinetic (PK) characteristics of colistin and to guide TDM in colistin-treated patients in Korea.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>In a prospective study, we analyzed PK characteristics in 15 patients who intravenously received colistin methanesulfonate twice per day. Colistin methanesulfonate doses were adjusted based on renal function of the subjects. The appropriate blood sampling points for TDM were evaluated by analyzing the correlations between the PK parameters and the plasma concentrations at each time point.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The mean values for the minimum, maximum, and average concentrations (C\n                      <jats:sub>min<\/jats:sub>\n                      , C\n                      <jats:sub>max<\/jats:sub>\n                      , and C\n                      <jats:sub>average<\/jats:sub>\n                      ) of colistin at steady state were 2.29, 5.5, and 3.38 mg\/L, respectively. The dose-normalized C\n                      <jats:sub>min<\/jats:sub>\n                      , C\n                      <jats:sub>max<\/jats:sub>\n                      , C\n                      <jats:sub>average<\/jats:sub>\n                      , and area under the plasma concentration\u2013time curve from 0 to the last measurable concentration (AUC\n                      <jats:sub>last<\/jats:sub>\n                      ) showed negative correlations with the creatinine clearance. The combination of the 0- and 2-hour post-dose plasma concentrations was evaluated as the appropriate sampling point for TDM. Two patients reported nephrotoxic adverse events during colistin administration.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Our study clarifies the PK characteristics of successful colistin treatment using TDM. Further evaluations in a larger patient population are needed to confirm the clinical usefulness of colistin TDM.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ftd.0000000000000572","type":"journal-article","created":{"date-parts":[[2018,10,5]],"date-time":"2018-10-05T20:36:02Z","timestamp":1538771762000},"page":"102-106","source":"Crossref","is-referenced-by-count":29,"title":["Pharmacokinetic Characteristics and Limited Sampling Strategies for Therapeutic Drug Monitoring of Colistin in Patients With Multidrug-Resistant Gram-Negative Bacterial Infections"],"prefix":"10.1097","volume":"41","author":[{"given":"Eun Jung","family":"Kim","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam"},{"name":"Department of Internal Medicine, Seoul National University College of Medicine, Seoul"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaeseong","family":"Oh","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyounghoon","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Seoul National University Bundang Hospital, Seongnam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung-Sang","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Yong","family":"Chung","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology and Therapeutics, Seoul National University Bundang Hospital, Seongnam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joo-Hee","family":"Hwang","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Young","family":"Nam","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyoung Sook","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Seoul National University Bundang Hospital, Seongnam, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moonsuk","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong Su","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Seoul National University Bundang Hospital, Seongnam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoung-Ho","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam"},{"name":"Department of Internal Medicine, Seoul National University College of Medicine, Seoul"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eu Suk","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam"},{"name":"Department of Internal Medicine, Seoul National University College of Medicine, Seoul"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junghan","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Seoul National University Bundang Hospital, Seongnam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong Bin","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam"},{"name":"Department of Internal Medicine, Seoul National University College of Medicine, Seoul"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230814","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1128\/AAC.01169-07","article-title":"Clinical and economic impact of common multidrug-resistant gram-negative bacilli","volume":"52","author":"Giske","year":"2008","journal-title":"Antimicrob Agents Chemother."},{"key":"R2-20230814","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1086\/429323","article-title":"Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections","volume":"40","author":"Falagas","year":"2005","journal-title":"Clin Infect Dis."},{"key":"R3-20230814","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1586\/eri.10.88","article-title":"Multidrug-resistant gram-negative infections: the use of colistin","volume":"8","author":"Michalopoulos","year":"2010","journal-title":"Expert Rev Anti Infect Ther."},{"key":"R4-20230814","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1592\/phco.30.12.1279","article-title":"Resurgence of colistin: a review of resistance, toxicity, pharmacodynamics, and dosing","volume":"30","author":"Lim","year":"2010","journal-title":"Pharmacotherapy"},{"key":"R5-20230814","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1093\/cid\/civ964","article-title":"Updated US and European dose recommendations for intravenous colistin: how do they perform?","volume":"62","author":"Nation","year":"2016","journal-title":"Clin Infect Dis."},{"key":"R6-20230814","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1053\/j.ajkd.2016.03.421","article-title":"Colistin use in patients with reduced kidney function","volume":"68","author":"Fiaccadori","year":"2016","journal-title":"Am J Kidney Dis."},{"key":"R7-20230814","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1248\/bpb.b15-00323","article-title":"Successful colistin treatment of multidrug-resistant pseudomonas aeruginosa infection using a rapid method for determination of colistin in plasma: usefulness of therapeutic drug monitoring","volume":"38","author":"Yamada","year":"2015","journal-title":"Biol Pharm Bull."},{"key":"R8-20230814","doi-asserted-by":"crossref","first-page":"2050313x17711630","DOI":"10.1177\/2050313X17711630","article-title":"Therapeutic drug monitoring for colistin therapy in severe multi-resistant Acinetobacter intracerebral abscess: a single case study with high-dose colistin and review of literature","volume":"5","author":"Tafelski","year":"2017","journal-title":"SAGE Open Med Case Rep."},{"key":"R9-20230814","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1469-0691.2011.03667.x","article-title":"Colistin pharmacokinetics: the fog is lifting","volume":"18","author":"Couet","year":"2012","journal-title":"Clin Microbiol Infect."},{"key":"R10-20230814","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.jpba.2008.12.016","article-title":"Quantitative analysis of colistin A and colistin B in plasma and culture medium using a simple precipitation step followed by LC\/MS\/MS","volume":"49","author":"Jansson","year":"2009","journal-title":"J Pharm Biomed Anal."},{"key":"R11-20230814","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1128\/AAC.01367-09","article-title":"Assay of colistin and colistin methanesulfonate in plasma and urine by liquid chromatography-tandem mass spectrometry","volume":"54","author":"Gobin","year":"2010","journal-title":"Antimicrob Agents Chemother."},{"key":"R12-20230814","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1186\/1471-2334-13-380","article-title":"Trough colistin plasma level is an independent risk factor for nephrotoxicity: a prospective observational cohort study","volume":"13","author":"Sorli","year":"2013","journal-title":"BMC Infect Dis."},{"key":"R13-20230814","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.ijantimicag.2016.08.020","article-title":"Validation of a colistin plasma concentration breakpoint as a predictor of nephrotoxicity in patients treated with colistin methanesulfonate","volume":"48","author":"Horcajada","year":"2016","journal-title":"Int J Antimicrob Agents"},{"key":"R14-20230814","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1093\/jac\/dkm511","article-title":"Comparison of once-, twice- and thrice-daily dosing of colistin on antibacterial effect and emergence of resistance: studies with pseudomonas aeruginosa in an in vitro pharmacodynamic model","volume":"61","author":"Bergen","year":"2008","journal-title":"J Antimicrob Chemother."},{"key":"R15-20230814","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1128\/AAC.01114-09","article-title":"Elucidation of the pharmacokinetic\/pharmacodynamic determinant of colistin activity against pseudomonas aeruginosa in murine thigh and lung infection models","volume":"54","author":"Dudhani","year":"2010","journal-title":"Antimicrob Agents Chemother."},{"key":"R16-20230814","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S0959-8049(99)00266-X","article-title":"A limited sampling strategy for determining carboplatin AUC and monitoring drug dosage","volume":"36","author":"Chatelut","year":"2000","journal-title":"Eur J Cancer"},{"key":"R17-20230814","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/FTD.0b013e3181a23f1a","article-title":"Limited sampling strategies for therapeutic drug monitoring of mycophenolate mofetil therapy in patients with autoimmune disease","volume":"31","author":"de Winter","year":"2009","journal-title":"Ther Drug Monit."},{"key":"R18-20230814","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000445896","article-title":"Limited sampling strategy for the estimation of tacrolimus area under the concentration-time curve in Chinese adult liver transplant patients","volume":"98","author":"Liu","year":"2016","journal-title":"Pharmacology"},{"key":"R19-20230814","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1159\/000187054","article-title":"Predicting glomerular function from adjusted serum creatinine","volume":"62","author":"Gault","year":"1992","journal-title":"Nephron"},{"key":"R20-20230814","doi-asserted-by":"crossref","first-page":"R204","DOI":"10.1186\/cc2872","article-title":"Acute renal failure\u2014definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group","volume":"8","author":"Bellomo","year":"2004","journal-title":"Crit Care"},{"key":"R21-20230814","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1128\/AAC.01733-10","article-title":"Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients","volume":"55","author":"Garonzik","year":"2011","journal-title":"Antimicrob Agents Chemother."},{"key":"R22-20230814","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1185\/03007995.2011.626557","article-title":"Safety and pharmacokinetic evaluation of intravenous colistin methanesulfonate sodium in Japanese healthy male subjects","volume":"27","author":"Mizuyachi","year":"2011","journal-title":"Curr Med Res Opin."},{"key":"R23-20230814","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/2110-5820-1-14","article-title":"Renal and neurological side effects of colistin in critically ill patients","volume":"1","author":"Spapen","year":"2011","journal-title":"Ann Intensive Care"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00007691-201902000-00014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T18:40:18Z","timestamp":1775241618000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007691-201902000-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000000572","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]}}}